New digital tool aims to simplify diabetes care for Alzheimer's patients

NCT ID NCT05643144

Recruiting now Knowledge-focused Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 4 times

Summary

This study tests a digital tool called CGM ASSIST that combines a continuous glucose monitor with easy-to-read displays. The goal is to help people with Alzheimer's or dementia and diabetes, along with their caregivers, better understand blood sugar levels and make informed decisions with their doctors. Sixty-two patient-caregiver pairs will wear the monitor for 14 days and complete surveys to see if the tool is useful and easy to use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Continuous Glucose Monitor (CGM) and interactive information display (CGM ASSIST)
What this could lead to: If successful, this could lead to a practical tool that helps families and doctors better manage diabetes in people with memory loss, reducing dangerous low blood sugar events.
What could go wrong: This is a small, early feasibility study with only 62 participants, so results may not apply to everyone. The tool may not be easy to use or may not improve health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE (INCL SUBTYPES) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease dementia diabetes mellitus hypoglycemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER'S DISEASE (INCL SUBTYPES) DEMENTIA DIABETES HYPOGLYCEMIA

Contacts and locations

Locations

Eskenazi Health
RECRUITING

Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.